A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof

A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof

The present invention related to a radiolabeled nucleoside analogue, wherein comprises a radioiodinated [123/131I] and a nucleoside analogue being selected from the group consisting of Cytosine, Thymine, Uracil, and analogues thereof. A method for the radiolabeled nucleoside analogue is also provide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WANG, HSIN-ELL, WENG, MAOI, LIN, WUU-JYH, WANG, MEI-HUI, CHANG, YU, CHEN, CHUAN-LIN, LIN, CHIH-YUAN, YU, HUNG-MAN, KUO, WEI-TI
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WANG, HSIN-ELL
WENG, MAOI
LIN, WUU-JYH
WANG, MEI-HUI
CHANG, YU
CHEN, CHUAN-LIN
LIN, CHIH-YUAN
YU, HUNG-MAN
KUO, WEI-TI
description The present invention related to a radiolabeled nucleoside analogue, wherein comprises a radioiodinated [123/131I] and a nucleoside analogue being selected from the group consisting of Cytosine, Thymine, Uracil, and analogues thereof. A method for the radiolabeled nucleoside analogue is also provided in the present invention and thereby, the nucleoside analogue with longer in vivo half-life time and higher stability in the serum may be produced. A pharmaceutical composition of radiolabeled nucleoside analogue is further provided for a promising proliferation probe for tumor diagnosis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW201228673A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW201228673A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW201228673A3</originalsourceid><addsrcrecordid>eNqNyksKwjAURuFMHIi6h-tcQVNQp0UUF1DosFybv20gzQ157F8qLsDRx4GzVm1NkY0Vx284GPKld5BkDYg9OxkLDsQ0I09iaJBIISJwtH6kPIESz8tpvlESFiNk2KrVwC5h93Oj9s9Hc38dEaRDCtzDI3dNq09nrW-Xa1VX_zwf_jM5Ug</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof</title><source>esp@cenet</source><creator>WANG, HSIN-ELL ; WENG, MAOI ; LIN, WUU-JYH ; WANG, MEI-HUI ; CHANG, YU ; CHEN, CHUAN-LIN ; LIN, CHIH-YUAN ; YU, HUNG-MAN ; KUO, WEI-TI</creator><creatorcontrib>WANG, HSIN-ELL ; WENG, MAOI ; LIN, WUU-JYH ; WANG, MEI-HUI ; CHANG, YU ; CHEN, CHUAN-LIN ; LIN, CHIH-YUAN ; YU, HUNG-MAN ; KUO, WEI-TI</creatorcontrib><description>The present invention related to a radiolabeled nucleoside analogue, wherein comprises a radioiodinated [123/131I] and a nucleoside analogue being selected from the group consisting of Cytosine, Thymine, Uracil, and analogues thereof. A method for the radiolabeled nucleoside analogue is also provided in the present invention and thereby, the nucleoside analogue with longer in vivo half-life time and higher stability in the serum may be produced. A pharmaceutical composition of radiolabeled nucleoside analogue is further provided for a promising proliferation probe for tumor diagnosis.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120716&amp;DB=EPODOC&amp;CC=TW&amp;NR=201228673A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120716&amp;DB=EPODOC&amp;CC=TW&amp;NR=201228673A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG, HSIN-ELL</creatorcontrib><creatorcontrib>WENG, MAOI</creatorcontrib><creatorcontrib>LIN, WUU-JYH</creatorcontrib><creatorcontrib>WANG, MEI-HUI</creatorcontrib><creatorcontrib>CHANG, YU</creatorcontrib><creatorcontrib>CHEN, CHUAN-LIN</creatorcontrib><creatorcontrib>LIN, CHIH-YUAN</creatorcontrib><creatorcontrib>YU, HUNG-MAN</creatorcontrib><creatorcontrib>KUO, WEI-TI</creatorcontrib><title>A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof</title><description>The present invention related to a radiolabeled nucleoside analogue, wherein comprises a radioiodinated [123/131I] and a nucleoside analogue being selected from the group consisting of Cytosine, Thymine, Uracil, and analogues thereof. A method for the radiolabeled nucleoside analogue is also provided in the present invention and thereby, the nucleoside analogue with longer in vivo half-life time and higher stability in the serum may be produced. A pharmaceutical composition of radiolabeled nucleoside analogue is further provided for a promising proliferation probe for tumor diagnosis.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyksKwjAURuFMHIi6h-tcQVNQp0UUF1DosFybv20gzQ157F8qLsDRx4GzVm1NkY0Vx284GPKld5BkDYg9OxkLDsQ0I09iaJBIISJwtH6kPIESz8tpvlESFiNk2KrVwC5h93Oj9s9Hc38dEaRDCtzDI3dNq09nrW-Xa1VX_zwf_jM5Ug</recordid><startdate>20120716</startdate><enddate>20120716</enddate><creator>WANG, HSIN-ELL</creator><creator>WENG, MAOI</creator><creator>LIN, WUU-JYH</creator><creator>WANG, MEI-HUI</creator><creator>CHANG, YU</creator><creator>CHEN, CHUAN-LIN</creator><creator>LIN, CHIH-YUAN</creator><creator>YU, HUNG-MAN</creator><creator>KUO, WEI-TI</creator><scope>EVB</scope></search><sort><creationdate>20120716</creationdate><title>A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof</title><author>WANG, HSIN-ELL ; WENG, MAOI ; LIN, WUU-JYH ; WANG, MEI-HUI ; CHANG, YU ; CHEN, CHUAN-LIN ; LIN, CHIH-YUAN ; YU, HUNG-MAN ; KUO, WEI-TI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW201228673A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2012</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG, HSIN-ELL</creatorcontrib><creatorcontrib>WENG, MAOI</creatorcontrib><creatorcontrib>LIN, WUU-JYH</creatorcontrib><creatorcontrib>WANG, MEI-HUI</creatorcontrib><creatorcontrib>CHANG, YU</creatorcontrib><creatorcontrib>CHEN, CHUAN-LIN</creatorcontrib><creatorcontrib>LIN, CHIH-YUAN</creatorcontrib><creatorcontrib>YU, HUNG-MAN</creatorcontrib><creatorcontrib>KUO, WEI-TI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG, HSIN-ELL</au><au>WENG, MAOI</au><au>LIN, WUU-JYH</au><au>WANG, MEI-HUI</au><au>CHANG, YU</au><au>CHEN, CHUAN-LIN</au><au>LIN, CHIH-YUAN</au><au>YU, HUNG-MAN</au><au>KUO, WEI-TI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof</title><date>2012-07-16</date><risdate>2012</risdate><abstract>The present invention related to a radiolabeled nucleoside analogue, wherein comprises a radioiodinated [123/131I] and a nucleoside analogue being selected from the group consisting of Cytosine, Thymine, Uracil, and analogues thereof. A method for the radiolabeled nucleoside analogue is also provided in the present invention and thereby, the nucleoside analogue with longer in vivo half-life time and higher stability in the serum may be produced. A pharmaceutical composition of radiolabeled nucleoside analogue is further provided for a promising proliferation probe for tumor diagnosis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW201228673A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG,%20HSIN-ELL&rft.date=2012-07-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW201228673A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true